ABSTRACT This study tested the hypothesis that pressure-controlled intermittent coronary sinus occlusion (PICSO) would be useful in ameliorating myocardial ischemia under conditions characterized by preserved, but reduced (relative to demand), myocardial blood flow. Studies were conducted in closed-chest, sedated domestic swine prepared with an artificial stenosis that reduced luminal diameter of the animal's left anterior descending coronary artery by 80%. Measurements of hemodynamics, regional myocardial blood flow, and oxygen, lactate, and nucleoside metabolism were obtained in 10 animals (1) before placement of stenosis, (2) 30 min after insertion of stenosis, (3) after 30 and 60 min of PICSO, and (4) 30 min after discontinuation of PICSO. Two groups of control animals were studied to observe the natural history of metabolic markers of ischemia. Control group I consisted of four animals studied concurrently and subjected to the same protocol except for the fact that PICSO was not applied. Control group II consisted of eight additional animals studied as a group. A specially designed balloon-tipped catheter positioned in the proximal portion of the animal's great cardiac vein was used to provide PICSO. Heart rate was controlled by atrial pacing (rate, 145 beats/min) through the study. After placement of the stenosis, flow in endocardial and transmural layers distal to the stenosis declined significantly (p<.01) vs control. Application of PICSO failed to increase arterial inflow distal to the stenosis in any myocardial layer. Myocardial aerobic metabolism was adversely affected by stenosis and changed from consumption of lactate, inosine, and hypoxanthine before stenosis to production at 30 min after stenosis. Although PICSO was associated with reduced production and a return toward consumption of lactate, inosine, and hypoxanthine, a similar pattern of changes in lactate, inosine, and hypoxanthine metabolism was observed in control animals over a comparable period of time. In addition, regional myocardial oxygen extraction and consumption were not changed vs poststenosis levels by PICSO. However, in comparison with controls, PICSO did accelerate the rate of resolution of myocardial ischemia as assessed by lactate metabolism. At 30 min of PICSO (or sham) the change vs poststenosis was + 33.6 + 25.0 ,mol/min/100 g in the PICSO but only + 6.7 ± 29.7 in the control group (p =.05). We conclude, therefore, that even though PICSO did not alter the final level of myocardial ischemia under conditions modeled in this study it did accelerate its rate of resolution, an effect that may be beneficial clinically. Circulation 77, No. 6, 1403No. 6, -1413No. 6, , 1988 PREVIOUS EXPERIMENTS in canine preparations of acute myocardial infarction indicate that pressurecontrolled intermittent coronary sinus occlusion (PICSO) may be of value in reducing infarct size' and in improving systolic function in the infarct zone.2 The mechanism(s) responsible for PICSO's beneficial ef-
zone.3 4 Accordingly, the present investigation was performed to test the hypothesis that PICSO may alleviate myocardial ischemia in a setting other than acute coronary artery occlusion. Testing this hypothesis also permitted us to indirectly assess the ability of PICSO to limit myocardial infarct size by improving the balance between myocardial oxygen supply and demand. Experiments were performed with sedated, closed-chest domestic swine instrumented to induce a severe (80% luminal diameter reduction) coronary arterial stenosis.3' Regional myocardial ischemia was induced by atrial pacing (145 beats/min) and confirmed by metabolic measurements of regional myocardial oxygen consumption, lactate, inosine, and hypoxanthine metabolism.
Materials and methods
Twenty-two swine (mean weight 39 kg, range 36 to 49, Charles River Lab) were premedicated with ketamine (25 mg/kg) and then anesthetized with halothane (0.5 to 1.5%) and nitrous oxide. After this, each animal was systemically anticoagulated with heparin (225 IU/kg, iv). Anesthetic gases were mixed with oxygen and delivered via an endotracheal tube with a volume-cycled respirator.
Instrumentation. A No. 7F end-hole catheter in the arch of the aorta was used to monitor pressure and to obtain blood for determination of pH, Po2, and Pco2 and to sample arterial levels of metabolites and radioactive microspheres for determination of regional myocardial blood flow. A No. 8F angiographic catheter was passed retrograde under fluoroscopic guidance from the femoral artery into the left atrium for administration of radioactive microspheres. A No. 7F pigtail catheter was passed under fluoroscopic guidance retrograde from the right brachial artery into the left ventricle for measurement of left ventricular pressure.
Pressure-controlled coronary sinus occlusion was performed with a No. 7F double-lumen catheter (Mansfield Scientific, Boston) inserted through the right jugular vein. The balloon was located 5 mm from the catheter tip and inflated up to 10 mm in diameter. The catheter was passed through the right atrium and positioned under fluoroscopic guidance in the coronary sinus just proximal to the entrance of the azyous vein. Through the lumen of the PICSO catheter, a No. 3F plastic catheter was passed into the anterior interventricular vein (AIV) and placed 3 to 5 cm distal to the PICSO catheter with the help of a 0.018 Teflon-coated guidewire with a 3 cm floppy distal end. The AIV catheter was used to selectively sample coronary venous blood draining from the myocardium in the distribution of the left anterior descending coronary artery. The heart was paced at a rate of 145 beats/min throughout the study by means of a No. 7F bipolar catheter introduced into the left jugular vein and positioned in the right atrium (figure 1).
After instrumentation, halothane and nitrous oxide were discontinued and the animal was weaned from the respirator. Small doses (20 to 30 mg) of intravenous sodium thiamylol were then given throughout the study to ensure that the animal was comfortable and resting quietly. Although sedated, each animal breathed spontaneously, was awake, and had intact corneal reflexes. All animals remained intubated and were given supplemental oxygen during the study. Arterial blood gases were monitored frequently and remained at appropriate levels (pH = 7.36 to 7 .46, Pco2 = 35 to 48, Po2 = 87 to 138 mm Hg) throughout the experiment. 1404 FIGURE 1 . A schematic view of the experimental preparation. The artificial stenosis is in the left anterior descending coronary artery (LAD). Blood draining from myocardium distal to the stenosis is sampled from the catheter in the AIV. The distal end of the AIV catheter is distal to the level of the LAD stenosis. Finally, the PICSO balloon is shown in the great cardiac vein on the anterolateral wall of the left ventricle.
Study protocol. After instrumentation, pacing at a rate of 145 beats/min was begun and continued for the duration of the study. When the animal was stabilized for at least 30 min, baseline determinations of myocardial blood flow were made by injection of radioactive labeled microspheres into the left atrium. Arterial and AIV blood gases, lactate, inosine, and hypoxanthine levels were also drawn.
At this point, a plastic stenosis (7.5 mm long, outer diameter 3.5 mm, inner diameter 0.625 mm) was placed in the proximal one-third of the left anterior descending coronary artery.3 5 The stenosis contained a second lumen into which the distal end of a 1.4 mm in diameter, 70 cm long plastic catheter had been attached before placement of the stenosis. The distal end of the catheter was opened to the distal end of the stenosis and was used to record pressure from the distal arterial bed. Repeat blood flow, metabolic, and hemodynamic measurements were made (1) 30 min after placement of stenosis, (2) at 30 and 60 min of PICSO (PICSO was begun after completion of the 30 min poststenosis measurements), and (3) 30 min after discontinuation of the 1 hr PICSO period. Blood for metabolic measurements at each time point was drawn simultaneously from the AIV and aorta.
PICSO was instituted at 30 min after insertion of stenosis, was continued for 1 hr, and was then discontinued in 10 study animals. The PICSO balloon was inflated until the AIV pressure reached approximately 90% of plateau for 3 to 4 beats (7 to 7.5 sec) and was then deflated. The inflation-deflation cycle (figure 2) was begun again 4 sec later. Inflation and deflation of the balloon was accomplished automatically with an electronic servocontrol device supplied by Mansfield Scientific (Boston). Blood for each metabolic variable was drawn over the course of two full PICSO inflation and deflation cycles. This was done to avoid possible sampling error secondary to PICSO inflation and increased AIV pressure. Four animals were identified prospectively and randomly as concurrent controls (control group I). They were studied over a 11/2hr period without the use of PICSO to observe the natural history of metabolic markers of ischemia in this preparation. After the initial studies, a second set of eight control animals (control group II) was prepared and studied as a group to confirm the observations made in control group I. The study protocol for control group II was similar to that for control group I with the exception that (1) AIV sampling was performed with a No. 3F or SF plastic catheter inserted without the use of the PICSO catheter, (2) heart rate was controlled at 130 to 140 beats/min, (3) inosine and hypoxanthine measurements were not obtained, and (4) observations were made before placement of stenosis and at 20, 60, 120, and 180 min after placement of stenosis.
After completion of the procotol, marker microspheres were injected through the stenosis catheter to delineate the ischemic area. The animal was given a large intravenous dose of sodium thiamylol and then killed 5 min later with an intravenous bolus of concentrated KCl. The heart was then removed and sectioned for determination of microsphere activity. Location of the stenosis and AIV catheter also was noted and gross inspection of the myocardium and coronary vessels was performed. The protocol for this study was Determination of regional inosine and hypoxanthine metabolism. Hypoxanthine and inosine concentrations in arterial and AIV blood samples (3 ml) were determined by high-pressure liquid chromatography. The method used was a modified version of one previously reported by us7 for determination of interstitial fluid adenosine concentration. Briefly, an aliquot of whole blood extract obtained for lactate measurement was neutralized by addition of a small voiume (-20 gl) of strong base (4.5M K2C03). Next, 100 ,A of the extract was injected on a C-18, VMA reverse-phase column and eluted with a linear gradient of 0 to 14% methanol over 15 min (flow rate, 2 ml/min). The eluent was monitored by a variable wavelength ultraviolet detector set at 262 nm. Peak heights were identified by comparing retention times with known standards. Enzymatic digestion to eliminate the peak and coinjection of known standards to augment the peak also were used initially to confirm peak identity. Measurement of peak height was used to quantitate the amount of inosine and hypoxanthine present in the sample. Regional extraction/production was calculated as the difference in the arterial and AIV concentrations multiplied by the transmural blood flow distal to the stenosis.
Statistical analysis. The significance of differences in group mean values was assessed by means of blocked, one-way analysis of variance and Newman-Keuls or Dunnett's test.8 Results were considered statistically significant at p<.05. All values are expressed as the mean + SD. Animals (n = 6) were excluded from the study if they failed to produce lactate at 30 min after placement of the stenosis.
Results
Hemodynamics (tables 1A, 1B, and 1C). As required by the study protocol, heart rate did not change significantly during the investigation. With placement of the stenosis, pressure in the left anterior descending coronary artery to the stenosis declined, as expected, in both the control and PICSO groups. The transstenotic mean pressure gradient was 47 ± 8 mm Hg in the PICSO group, 49 + 7 mm Hg in control group I, and 46 + 13 mm Hg in control group II (p = NS). PICSO did not affect any of the hemodynamic variables measured, although minor cyclical augmentation of distal coronary pressure did occur with each PICSO cycle (figure 2). Hemodynamics in both control groups also remained constant throughout the protocol.
Regional myocardial blood flow (tables 2A, 2B, and 2C) PICSO group. After placement of the stenosis, endocardial and transmural blood flow in the distal zone decined (p<.01) vs prestenosis levels. In contrast, epicardial blood flow in the distal zone did not change significantly vs its prestenosis value after insertion of the stenosis. Application and subsequent discontinuation of PICSO had no significant effect on antegrade myocardial blood flow in any layer of the distal zone. Myocardial blood flow in all layers of the circumflex zone remained constant relative to initial prestenosis values throughout the entire study.
Control group!. The pattern of both distal and circumflex zone blood flow responses to insertion of the stenosis was identical to that seen in the PICSO group. Thus, both endocardial and transmural flow in the distal zone declined significantly vs prestenosis levels after placement of the stenosis. Epicardial flow in the distal zone did not change significantly vs prestenosis levels after insertion of the stenosis. Myocardial flows in all layers of both zones remained unchanged vs poststenosis values for the remainder of the study.
Control group H. Distal zone myocardial blood flow responses in this group were similar to those observed in the others. Thus, transmural and endocardial flow declined vs control 5 min after placement of the stenosis and then remained essentially unchanged for the remainder of the 3 hr observation period. Distal zone epicardial flow actually increased modestly but significantly (p<.05) in comparison with before stenosis at 5, 20, and 60 min after stenosis. Although values of distal zone epicardial flow at 2 and 3 hr after stenosis did not differ significantly from prestenosis levels, it is apparent that they were very similar to and also did not differ significantly from 1 hr poststenosis levels.
Regional myocardial oxygen metabolism (tables 3A, 3B, and 3C) PICSO group. Arterial oxygen content remained constant vs prestenosis levels during the entire study. After insertion of the stenosis AIV oxygen content declined significantly (p<.05) and regional myocardial oxygen extraction increased significantly (p<.05) vs prestenosis values. Despite the increase in regional myocardial oxygen extraction, regional myocardial oxygen consumption declined significantly (p<.05) vs prestenosis levels after placement of the stenosis.
CIRCULATION 1406 study. Discontinuation of PICSO was not associated with an increase in production of any metabolite. The levels of lactate, inosine, and hypoxanthine production after 60 min of PICSO did not differ significantly from respective levels 30 min after discontinuation of PICSO.
Control group I. Arterial concentrations of lactate, inosine, and hypoxanthine remained constant throughout the study save for a small but statistically significant reduction (vs prestenosis levels) in inosine concentration in the sham post-PICSO period. In contrast, AIV concentrations of lactate and inosine increased significantly vs prestenosis values after placement of the stenosis. Hypoxanthine concentration in AIV blood, however, remained constant during the study. Before placement of stenosis, all metabolites exhibited con- 1410 CIRCULATION sumption across the distal coronary bed. After insertion of the stenosis, a significant change from consumption to production of all metabolites was observed. Regional myocardial production of lactate tended to decrease, but not significantly, during and after the sham PICSO period. Inosine production during and after the sham PICSO period was significantly (p<.01) reduced vs the value measured at 30 min after stenosis. Finally, hypoxanthine production during and after the sham PICSO period tended to decline vs the 30 min poststenosis level, although the change was not statistically significant. Control group II. Arterial lactate concentration did not change significantly vs that before stenosis at any time after its placement. In contrast, anterior interventricular vein lactate concentration increased significantly vs that before stenosis at both 5 and 20 min after stenosis and then declined to levels that did not differ significantly from prestenosis levels at 1, 2, and 3 hr after stenosis. Lactate concentration in AIV blood at 5 min after stenosis was elevated (p<.01) in comparison with all other poststenosis values. Lactate utilization changed from consumption after stenosis to production at 5, 20, and 60 min after stenosis (all p<.01). At 2 and 3 hr after stenosis lactate utilization was on the borderline between production and consumption. Values measured at both time points differed significantly from both prestenosis (p<.05) and 5 min poststenosis levels (p<.01). Lactate utilization at 20 and 60 min after stenosis also differed significantly (p<.05) from that 5 min after stenosis.
Lactate levels: PICSO vs controls. In the prestenosis period lactate utilization was lower in the PICSO group (21.2 ± 12.7 ,umol/min/100 g) than in either control group (control I, 49.0 ± 19.2 gmol/min/100 g, p<.O5; control II, 36.7 ± 27.3 ,umol/min/100 g, p = NS). Similarly, at 30 min after stenosis (or in control group II, 20 min after stenosis), lactate utilization was lower in the PICSO group (-46.6 ± 37.5 gumol/ min/100 g) than in either of the control groups (control I, -13.9 ± 7.2 ,umol/min/100 g, p =NS; control II, -18.0 ± 25.2 ,umol/min/100 g, p =NS). min/100 g; controls= -57.3 + 36.4 gimol/min/100 g). Second, the change between the poststenosis measurement (using the 20 min time point for control group II) and 30 min of PICSO (or sham) was + 33.6 ± 25.0 gmol/min/100 g for the PICSO group and + 6.7 ± 29.7 gmol/min/100 g for control (p = .05).
Third, changes in lactate production between the 30 min PICSO (or sham) and the post-PICSO (or after sham PICSO) measurement approached zero for each group (5.4 ± 24.2 and 9.4 ± 22.4 ,umol/min/100 g, respectively). However, the final levels of ischemia were similar in PICSO (-7.6 ± 19.1 gmol/min/100 g) and control groups (-0.60 ± 10.3 gmol/min/100 g) and did not differ significantly.
Discussion
PICSO has been proposed as a method for reducing infarct size in patients with acute myocardial infarction. l 2However, neither the mechanism of action nor the efficacy of this intervention has been established. Two recent studies failed to demonstrate any benefit of coronary sinus occlusion in reducing infarct size, one in dogs in which a pressure-controlled technique was used,9 the other in swine in which a time-controlled technique was used. 10 In contrast, another canine study found a reduction in infarct size in animals treated with PICSO.l The mechanism responsible for the beneficial effect in the latter study was not established, although it has been hypothesized that "washout of toxic metabolites" may be involved.2 Whether or not PICSO can improve myocardial ischemia under circumstances in which flow to the ischemic zone is preserved (albeit reduced in proportion to myocardial oxygen demand) also is unknown. The present study was therefore performed in an animal preparation in which myocardial ischemia was induced by rapid atrial pacing in the setting of a severe coronary arterial stenosis. Antegrade blood flow to the ischemic area was well maintained in this preparation (in comparison with the traditional infarct model), and so it provided an opportunity to test the hypothesis that PICSO may have a beneficial effect on myocardial ischemia in a setting other than that of an acute coronary artery occlusion.
After placement of the stenosis, a consistent metabolic pattern indicative of myocardial ischemia was observed in both PICSO and control animals. Thus, regional myocardial oxygen consumption declined11 and inosine and hypoxanthine production'2-15 developed. Lactate production,'4-17 of course, was observed in all animals since it represented an inclusion criteria of the study. Application of PICSO for 1 hr was associated with a reduction in the level of myocardial ische-mia as defined metabolically. Nevertheless, it is difficult to attribute metabolic improvement exclusively to PICSO for two reasons. First, controls exhibited a similar pattern of changes in regional myocardial oxygen consumption (group I and II), lactate (group I and II), inosine (group I), and hypoxanthine (group I) metabolism. Second, discontinuation of PICSO was not associated with evidence of worsening ischemia (i.e., increased production of inosine, hypoxanthine, and lactate and further reduction in myocardial oxygen consumption). Accordingly, a conservative interpretation of the data suggests the conclusion that, in the long run, myocardial ischemia was not improved by PICSO. It is important to note, however, that PICSO did exert a beneficial effect in terms of accelerating the rate at which lactate production declined (i.e., ischemia improved) soon after placement of stenosis, even though it appeared to have no effect on the final level of ischemia.
The fact that PICSO failed to influence the final level of myocardial ischemia attained in the present study, however, does not necessarily prove it is without value in the setting of acute myocardial infarction. The natural tendency of acutely ischemic myocardium to progress from a state of reversible ischemia to one of infarction in the presence of an abrupt coronary artery occlusion is well known.18 PICSO could be effective in reducing the ultimate size of myocardial infarction, but this reduction may not be accompanied by substantial improvement in indexes of myocardial aerobic metabolism for two reasons. First, "stunned" myocardium is known to exist in the infarct zone19 and could be responsible for failure of PICSO to increase regional myocardial oxygen consumption acutely (i.e., within the first hour of intervention). In addition, the mechanism responsible for reduction of infarct size simply may not work through the myocardial oxygen supply/ demand axis. Accordingly, failure of PICSO to effect the final, steady-state level of myocardial ischemia under conditions of relative preservation of arterial inflow does not mean the intervention lacks efficacy in the setting of infarction.
It is important to emphasize that the animals used in the present study exhibited spontaneous improvement in metabolic markers of myocardial ischemia (i.e., they became less ischemic), despite the fact that external determinants of myocardial oxygen demand and regional myocardial blood flow remained constant after insertion of the stenosis. Thus, production of inosine, hypoxanthine, and lactate tended to decrease (vs levels observed at 30 min after stenosis) during the course of the study. Exhaustion of metabolic substrates 1412 cannot account for this observation, since regional myocardial blood flow after placement of stenosis was unchanged vs prestenosis levels in the epicardium and was roughly 60% of prestenosis levels in the endocardium. Although regional myocardial oxygen consumption after insertion of the stenosis remained constant for the duration of the study, additional depression of myocardial contractility may have occurred, particularly in the endocardium. Reduced production of lactate, inosine, and hypoxanthine, therefore, likely reflects a better balance between myocardial oxygen supply and demand achieved as a result of a time-dependent (and in view of the limited oxygen supply, probably beneficial) depression of myocardial contractility. Failure of transmural myocardial oxygen consumption to decline may have been due to the fact that epicardial oxygen consumption increased as endocardial oxygen consumption declined.
Failure of PICSO to have a substantial beneficial effect on the final level of myocardial ischemia in the present study was likely related to two factors. First, arterial inflow to endocardial layers of the heart distal to the stenosis was unchanged by PICSO. In addition, the intervention was unable to enhance oxygen extraction by the myocardium. Thus, failure of PICSO to improve the final level of ischemia in part was due to its inability to increase oxygen delivery to the ischemic zone. Second, in contrast to the coronary occlusion preparation, myocardial ischemia tends to be selflimiting under conditions in which there is relative preservation of arterial inflow.4 Accordingly, the natural ability of the myocardium to limit ischemia under such circumstances likely overshadowed any potential beneficial effect the intervention might have had in the absence of spontaneous but gradual long-term improvement. Finally, it should be noted that the PICSO inflation/deflation cycle was closely and carefully monitored throughout each experiment (figure 2).
Thus, it is most unlikely that failure of PICSO to lessen the final level of myocardial ischemia in the present study was related to technical errors in applying the intervention.
One other methodologic issue should be considered; namely, the comparability of control and PICSO groups before treatment. Although the PICSO group and control group I differed significantly with respect to myocardial oxygen consumption and lactate utilization before placement of stenosis, the PICSO group and control group II did not. Thus, while it is possible that pretreatment differences between PICSO and control group 1 may have prevented recognition of a favorable effect for PICSO in terms of the final degree of CIRCULATION myocardial ischemia attained, we think it unlikely for two reasons. First, control group II attained the same final level of ichemia as the PICSO group, but did not differ with respect to pretreatment levels for these variables. Second, as demonstrated earlier, prestenosis differences in lactate utilization (1) did not result in significant poststenosis, pre-PICSO differences after the control groups were combined, and (2) did not prevent recognition of a favorable PICSO effect with respect to enhancement of the initial rate of resolution of ischemia.
In conclusion, data obtained in this investigation demonstrated that PICSO does not have a major beneficial effect on the ultimate, steady-state level of myocardial ischemia induced by atrial pacing in the setting of a severe coronary arterial stenosis. The intervention, however, does appear to have a positive effect in terms of accelerating the natural tendency toward metabolic improvement in this experimental setting. The mechanism involved in accelerating resolution of ischemia and the clinical significance of this effect cannot be stated based on the data obtained in this study. It is possible, however, that accelerating the rate at which myocardial ischemia resolves would be advantageous clinically because (1) it might permit other interventions (e.g., cardiac catheterization) to be performed more expeditiously and with greater safety, and (2) it might reduce the frequency of ischemiarelated morbid events (e.g., ventricular tachycardia/fibrillation) by decreasing the period of time during which the heart is susceptible to them. Additional clinical studies are needed to test both hypotheses.
